Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (221-230 of 778) with videos related to

Pageof 78
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 30, 2020
PCR e-Course: reshaping education in exceptional circumstancesSalvatore Brugaletta, Davide Capodanno, Jean Fajadet, et al.
International Journal of Cardiology|August 25, 2015
Risk stratification for secondary prevention with ticagrelor and aspirin: A closer look to patient subsets from the PEGASUS-TIMI 54 trialDavide Capodanno, Piera Capranzano, Sergio Buccheri, et al.
Journal of the American College of Cardiology|February 18, 2014
Mechanisms, pathophysiology, and clinical aspects of incomplete stent appositionGuilherme F Attizzani, Davide Capodanno, Yohei Ohno, et al.
Expert Opinion on Drug Safety|August 5, 2023
Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromesGiovanni Occhipinti, Antonio Greco, Dominick J Angiolillo, et al.
Recenti Progressi in Medicina|October 13, 2011
[Management of severe stenosis controversies and promises]Marco Barbanti, Davide Capodanno, Gian Paolo Ussia, et al.
Expert Opinion on Drug Safety|October 19, 2019
Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigmsSergio Buccheri, Davide Capodanno, Stefan James, et al.
European Heart Journal|January 5, 2018
The year in cardiology 2017: coronary interventionsSteen Dalby Kristensen, Michael Maeng, Davide Capodanno, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 28, 2017
State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectivesGiuseppe Gargiulo, Marco Valgimigli, Davide Capodanno, et al.
Future Cardiology|December 18, 2009
Transcatheter aortic valve implantation: what has been done and what is going to be doneCorrado Tamburino, Marco Barbanti, Davide Capodanno, et al.
International Journal of Cardiology|May 7, 2013
Meta-analysis of everolimus-eluting stents versus first-generation drug-eluting stents in patients with left main coronary artery undergoing percutaneous coronary interventionDavide Capodanno, Piera Capranzano, Alessio La Manna, et al.
Pageof 78

Showing results (221-230 of 778) with videos related to

Sort By:
Pageof 78
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 30, 2020
PCR e-Course: reshaping education in exceptional circumstancesSalvatore Brugaletta, Davide Capodanno, Jean Fajadet, et al.
International Journal of Cardiology|August 25, 2015
Risk stratification for secondary prevention with ticagrelor and aspirin: A closer look to patient subsets from the PEGASUS-TIMI 54 trialDavide Capodanno, Piera Capranzano, Sergio Buccheri, et al.
Journal of the American College of Cardiology|February 18, 2014
Mechanisms, pathophysiology, and clinical aspects of incomplete stent appositionGuilherme F Attizzani, Davide Capodanno, Yohei Ohno, et al.
Expert Opinion on Drug Safety|August 5, 2023
Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromesGiovanni Occhipinti, Antonio Greco, Dominick J Angiolillo, et al.
Recenti Progressi in Medicina|October 13, 2011
[Management of severe stenosis controversies and promises]Marco Barbanti, Davide Capodanno, Gian Paolo Ussia, et al.
Expert Opinion on Drug Safety|October 19, 2019
Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigmsSergio Buccheri, Davide Capodanno, Stefan James, et al.
European Heart Journal|January 5, 2018
The year in cardiology 2017: coronary interventionsSteen Dalby Kristensen, Michael Maeng, Davide Capodanno, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 28, 2017
State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectivesGiuseppe Gargiulo, Marco Valgimigli, Davide Capodanno, et al.
Future Cardiology|December 18, 2009
Transcatheter aortic valve implantation: what has been done and what is going to be doneCorrado Tamburino, Marco Barbanti, Davide Capodanno, et al.
International Journal of Cardiology|May 7, 2013
Meta-analysis of everolimus-eluting stents versus first-generation drug-eluting stents in patients with left main coronary artery undergoing percutaneous coronary interventionDavide Capodanno, Piera Capranzano, Alessio La Manna, et al.
Pageof 78